126 related articles for article (PubMed ID: 9401809)
1. In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin.
Martin SJ; Pendland SL; Chen C; Schreckenberger PC; Danziger LH
Diagn Microbiol Infect Dis; 1997 Nov; 29(3):167-71. PubMed ID: 9401809
[TBL] [Abstract][Full Text] [Related]
2. In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella.
Martin SJ; Pendland SL; Chen C; Schreckenberger P; Danziger LH
Antimicrob Agents Chemother; 1996 Jun; 40(6):1419-21. PubMed ID: 8726012
[TBL] [Abstract][Full Text] [Related]
3. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.
Baltch AL; Smith RP; Ritz W
Antimicrob Agents Chemother; 1995 Aug; 39(8):1661-6. PubMed ID: 7486896
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
Dubois J; St-Pierre C
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):261-5. PubMed ID: 10212753
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
Dubois J; St-Pierre C
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
[TBL] [Abstract][Full Text] [Related]
7. Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.
Pendland SL; Martin SJ; Chen C; Schreckenberger PC; Danziger LH
J Clin Microbiol; 1997 Nov; 35(11):3004-6. PubMed ID: 9350781
[TBL] [Abstract][Full Text] [Related]
8. Anti-Legionella activity of trovafloxacin compared with seven other antimicrobial agents including an intermethod evaluation.
Marco F; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 1997 Sep; 29(1):55-7. PubMed ID: 9350417
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia.
Edelstein PH; Edelstein MA; Lehr KH; Ren J
J Antimicrob Chemother; 1996 Jan; 37(1):117-26. PubMed ID: 8647752
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of various antibiotics against clinical strains of Legionella species isolated in Japan.
Miyashita N; Kobayashi I; Higa F; Aoki Y; Kikuchi T; Seki M; Tateda K; Maki N; Uchino K; Ogasawara K; Kurachi S; Ishikawa T; Ishimura Y; Kanesaka I; Kiyota H; Watanabe A
J Infect Chemother; 2018 May; 24(5):325-329. PubMed ID: 29459000
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Visalli MA; Jacobs MR; Appelbaum PC
Diagn Microbiol Infect Dis; 1997 Jul; 28(3):131-7. PubMed ID: 9294703
[TBL] [Abstract][Full Text] [Related]
12. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.
Stout JE; Sens K; Mietzner S; Obman A; Yu VL
Int J Antimicrob Agents; 2005 Apr; 25(4):302-7. PubMed ID: 15784309
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility study of BMS-284756 against Legionella species.
Dubois J; St-Pierre C
Diagn Microbiol Infect Dis; 2001; 41(1-2):79-82. PubMed ID: 11687318
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity and postantibiotic effect of clarithromycin and 14-hydroxyclarithromycin, alone and in combination, against Legionella pneumophila.
Martin SJ; Pendland SL
J Antimicrob Chemother; 1998 Jun; 41(6):643-8. PubMed ID: 9687103
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic efficacy of levofloxacin against a model of replicable Legionella pneumophila lung infection in DBA/2 mice].
Kashimoto Y; Kurosaka Y; Karibe Y; Uoyama S; Fujikawa K; Namba K; Otani T; Yamaguchi K
Jpn J Antibiot; 2009 Oct; 62(5):452-9. PubMed ID: 20055122
[TBL] [Abstract][Full Text] [Related]
16. Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes.
Smith RP; Baltch AL; Franke M; Hioe W; Ritz W; Michelsen P
J Antimicrob Chemother; 1997 Nov; 40(5):673-8. PubMed ID: 9421315
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila.
Baltch AL; Smith RP; Franke MA; Michelsen PB
Antimicrob Agents Chemother; 1998 Dec; 42(12):3153-6. PubMed ID: 9835507
[TBL] [Abstract][Full Text] [Related]
18. Environmental surveillance and in vitro activity of antimicrobial agents against Legionella pneumophila isolated from hospital water systems in Campania, South Italy: a 5-year study.
Torre I; Alfano R; Borriello T; De Giglio O; Iervolino C; Montagna MT; Scamardo MS; Pennino F
Environ Res; 2018 Jul; 164():574-579. PubMed ID: 29625340
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of antimicrobial agents against Legionella isolated from environmental water systems: first results from Turkey.
Erdogan H; Can F; Demirbilek M; Timurkaynak F; Arslan H
Environ Monit Assess; 2010 Dec; 171(1-4):487-91. PubMed ID: 20049525
[TBL] [Abstract][Full Text] [Related]
20. The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results.
Ruckdeschel G; Dalhoff A
J Antimicrob Chemother; 1999 May; 43 Suppl B():25-9. PubMed ID: 10382872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
